APUS
Apimeds Pharmaceuticals US, Inc.
NYSE MKT: APUS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
+0.00% today
Updated 2026-04-29
Market cap
$2.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Apimeds Pharmaceuticals US, Inc. (APUS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $172169.00 | $6171.00 | $422076.00 | $13057.00 |
| Cash & equivalents | $171438.00 | $6171.00 | $410481.00 | $3455.00 |
| Current assets | $172169.00 | $6171.00 | $422076.00 | $13057.00 |
| Total liabilities | $410652.00 | $719777.00 | $390205.00 | $1.37M |
| Current liabilities | $10652.00 | $319777.00 | $123314.00 | $1.02M |
| Long-term debt | $400000.00 | $400000.00 | $266891.00 | $346844.00 |
| Shareholder equity | $-238483.00 | $-713606.00 | $31871.00 | $-1.36M |
| Retained earnings | $-1.56M | $-2.22M | $-3.00M | $-4.39M |
| Accounts receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Goodwill | — | — | — | — |